MedTrace Logo

Polarization Sensitive Optical Coherence Tomography

NCT05809674 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2023-04-12

No results posted yet for this study

Summary

The purpose of the study is to use the polarization sensitive optical coherence tomography (PS-OCT) developed by Singapore Eye Research Institute, to evaluate the potential OCT scleral biomarkers capable of predicting risk of myopia progression.

Conditions

  • Myopia

Interventions

DEVICE

Polarization sensitive optical coherence tomography (PS-OCT)

The PS-OCT is a prototype, also known as an early version of a medical device, specially developed by the Ocular Imaging Research Group, Singapore Eye Research Institute, for prediction of myopia progression. It has not been approved for use in any other country. There is currently no method to identify who is at risk of myopia progression. The PS-OCT device will provide the capabilities of OCT scleral biomarkers, which may have the potential to identify individuals at high risk for myopia.

Sponsors & Collaborators

  • Singapore Eye Research Institute

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-10
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05809674 on ClinicalTrials.gov